Home Life Sciences Progress in research on the role of fibrinogen in lung cancer
Article Open Access

Progress in research on the role of fibrinogen in lung cancer

  • and EMAIL logo
Published/Copyright: June 5, 2020

Abstract

Lung cancer is one of the most prevalent malignancies worldwide. Local recurrence and distant metastasis remain the major causes of treatment failure. It has been recognized that the process of tumor growth and metastasis involves multiple interactions between tumor and host. Various biomarkers have been used for predicting tumor recurrence, metastasis, and prognosis in patients with lung cancer. However, these biomarkers are still controversial and require further validation. The relationship between malignancy and coagulation system disorders has been explored for more than a century. Fibrinogen is the most abundant plasma coagulation factor synthesized mainly by hepatic cells. Increased plasma fibrinogen levels were observed in various carcinomas such as gastric cancer, colon cancer, and pancreatic cancer. Recent studies have also investigated the role of fibrinogen in patients with lung cancer. This review aimed to address the role of fibrinogen in lung cancer.

1 Introduction

Lung cancer is a leading cause of cancer death around the world. The 5-year survival rate is only 15%, although various therapies are adopted [1]. Local recurrence and distant metastasis are the main reasons for treatment failure. Numerous factors including carcinoembryonic antigen, neuron-specific enolase, cytokeratin-19 fragments (CYFRA 21-1), and D-dimer for early diagnosis of distant metastasis, tumor recurrence, and prognosis in patients with lung cancer have been intensively identified [2,3]. However, the majority of these conventional indicators are still unsatisfactory.

Tumor-induced coagulation system disorders are commonly implicated in patients with malignancies. Fibrinogen is an essential constituent of the coagulation system. It is mainly synthesized in the liver and released into the circulation in response to systemic inflammation and malignancy. An increasing body of evidence has indicated the association between fibrinogen and tumor clinical stage, angiogenesis, metastatic spread, and response to therapy in patients with cancer [4,5]. The clinical value of fibrinogen in patients with lung cancer has also been investigated previously. To further understand its role, we reviewed fibrinogen estimation in patients with lung cancer.

2 Fibrinogen expression in lung cancer

High levels of fibrinogen have been observed in patients with lung cancer (Table 1). Kim et al. [9] reported that serum fibrinogen levels were increased in about 55.2% of patients with advanced non-small cell lung cancer (NSCLC), and its concentration may be higher in patients with squamous cell carcinoma than in patients with adenocarcinoma (4.5 ± 0.13 g/L vs 3.6 ± 0.28 g/L, p = 0.008) [4]. Elevated serum fibrinogen concentration can change blood viscosity, rheology, and endothelial function, which may facilitate microthrombosis in the pulmonary capillaries and make patients vulnerable to inflammation and ischemia [10,11]. Therefore, detection of serum fibrinogen levels may reflect lung tissue destruction. As previously reported, mean plasma fibrinogen concentration was associated with the pathological T stage but not with the pathological N stage [4]. However, other investigators found that there were no statistically significant differences in fibrinogen levels according to the TNM stage [9].

Table 1

The expression of fibrinogen in lung cancer

Histology (n)nParameters evaluatedMain outcome of the studyRef.
AC (18), SQ (69), LCC (2), other NSCLC (3)93FibrinogenElevated plasma fibrinogen level was positively correlated with increasing tumor size, advanced pathological T stage, and SCC.[4]
NS55Fibrinogen and FDPSerum fibrinogen and FDP levels were elevated in lung cancer patients with metastases.[6]
AC (165), SQ (106), LCC (22), SCC (46)339FibrinogenIncreased serum fibrinogen levels were associated with advanced SCC or LCC.[7]
AC (114), SQ (61), other NSCLC (9)184FibrinogenHigh pre- and postoperative fibrinogen levels in patients with NSCLC were associated with lymph node involvement of the tumor and pathologic stages.[8]

AC, adenocarcinoma; FDP, fibrinogen degradation product; LCC, large cell carcinoma; n, number of specimens; NS, not specified; NSCLC, non-small cell lung cancer; SCC, small cell carcinoma; SQ, squamous cell lung cancer.

Guan et al. [12] explored the relationship between fibrinogen and epidermal growth factor receptor (EGFR) mutation status in patients with NSCLC; they found that plasma fibrinogen levels were distinctly higher in patients with wild-type EGFR gene than in patients with EGFR mutations (3.57 g/L vs 2.95 g/L, p < 0.001). This shows that fibrinogen may assist in predicting EGFR mutation status in patients with NSCLC. However, additional studies are required to fully illustrate the molecular mechanism between fibrinogen and EGFR gene mutation status.

3 Role of fibrinogen in tumor progression

Cancer-related coagulation disorders have been thought to be responsible for the tumor cell growth, invasion, and distant metastasis. Recently, a series of experiments have shown the significance of fibrinogen in the pathogenesis of the cancer process [13,14,15]. As tumor cells dissociate from the primary focus into the circulation, fibrinogen can serve as a scaffold to bind tumor cells and platelets [15], which in turn contributes to tumor cell adherence to the distant organ and promotes tumor angiogenesis. Furthermore, fibrinogen has been implicated in the formation of tumor stroma, which provides gas exchange and nutrient for rapidly proliferating tumor cells.

Palumbo et al. [16] demonstrated that the deficiency of fibrinogen strongly reduced the spontaneous metastatic potential through both hematogenous and lymphatic routes but has no influences on the time required for the formation of palpable tumors, angiogenesis, and overall tumor architecture. Similarly, Palumbo et al. [17] also found that fibrinogen deficiency dramatically reduced the incidence of pulmonary metastases in fibrinogen-deficient transgenic mice. However, additional experiments are required to fully illustrate the relationship between fibrinogen and tumor metastasis.

As an extracellular protein matrix, fibrinogen not only promotes the migration of tumor cells but also protects tumor cells from the innate immune surveillance systems [14]. Zheng et al. [18] reported that fibrinogen can protect tumor cells from natural killer (NK) cell-mediated cytotoxicity by accumulating and forming dense fibrin layers around tumor cells. Gropp et al. [6] also found that fibrinogen split products can suppress immune reactions. Therefore, we can make the treatment more effective for patients with cancer by reducing the activity of the coagulation system.

4 Fibrinogen and the prognosis of lung cancer

The potential predictive value of fibrinogen for prognosis in patients with lung cancer has been reported in the previous investigations (Table 2). A significant relationship between initial response to chemotherapy and decreased fibrinogen levels was found in patients with elevated plasma levels of fibrinogen [5]. Jones et al. [4] reported that high fibrinogen values (plasma fibrinogen >5 g/L) were related to incomplete resection in patients with NSCLC. A retrospective analysis explored the correlation between preoperative serum fibrinogen levels and postoperative pulmonary complications (PPCs) in patients who underwent lung cancer resection. They found that high levels of preoperative serum fibrinogen (>400 mg/dL) were associated with the increased risk of PPCs, and it was an independent predictor regardless of sex and smoking status [30]. Jiang et al. [8] evaluated the value of pre- and postoperative plasma fibrinogen levels in predicting tumor recurrence and metastasis in 184 patients with I–IIIA NSCLC, who underwent radical surgery. They found a correlation between high pre- and postoperative plasma fibrinogen levels and tumor recurrence. This indicated that plasma fibrinogen levels may be used to predict tumor metastasis and recurrence for lung cancer patients who underwent surgery.

Table 2

Fibrinogen and the prognosis of lung cancer

Parameters evaluatedMain outcome of the studyRef.
FibrinogenHigh fibrinogen values were associated with incomplete resection in NSCLC.[4]
FibrinogenThe reduction of plasma fibrinogen levels can evaluate the efficacy of chemotherapy in advanced NSCLC.[5]
FibrinogenPre- and postoperative plasma fibrinogen levels can predict tumor recurrence and metastasis for patients with NSCLC.[8]
FibrinogenHigh fibrinogen levels were associated with poor prognosis in patients with advanced NSCLC.[9]
FibrinogenPreoperative serum fibrinogen level was an independent prognostic marker in patients with operable NSCLC.[19]
FibrinogenHigh plasma fibrinogen concentration indicated poor prognosis for NSCLC patients with brain metastases.[20]
FibrinogenPlasma fibrinogen can predict the chemotherapy efficacy for patients with SCLC.[21]
Fibrinogen, NLRPlasma fibrinogen and NLR may predict the prognosis of patients with resectable NSCLC.[22]
FA scoreThe FA score may be a promising prognostic predictor in patients with NSCLC.[23]
AFRHigh pre-resection AFR was associated with longer OS and disease-free survival (DFS) of patients with NSCLC.[24]
Fibrinogen, AFRAFR and fibrinogen were promising biomarkers to predict the clinical outcome of patients with NSCLC.[25]
Fibrinogen, NLRCombined fibrinogen and NLR can be used to predict prognosis for patients with resectable early-stage NSCLC.[26]
AFRPretreatment AFR can predict the survival of patients with advanced NSCLC, who underwent first-line platinum-based chemotherapy.[27]
FibrinogenFibrinogen levels may influence the PFS of patients with NSCLC.[28]
Fibrinogen, NLRCombination of fibrinogen and NLR can predict tumor progression and the postoperative survival of patients with NSCLC.[29]

AFR, albumin/fibrinogen ratio; FA score, fibrinogen and serum albumin levels; NLR, neutrophil-to-lymphocyte ratio; NSCLC, non–small cell lung cancer; SCLC, small cell lung cancer.

Several investigators reported that patients with higher plasma fibrinogen levels tend to have poor progression-free survival (PFS) and overall survival (OS) [19,21]. A meta-analysis suggested that the level of plasma fibrinogen ≥400 mg/dL could be a promising indicator for worse OS in patients with lung cancer [31]. Ying et al. [27] explored the usefulness of the albumin-to-fibrinogen ratio (AFR) in patients with advanced NSCLC; they found that the PFS and OS in the high AFR group (>8.02) were markedly improved compared with those in the low AFR group. Therefore, fibrinogen may serve as a candidate biomarker for disease monitoring and prognostic evaluation in patients with lung cancer.

5 Fibrinogen and the treatment of lung cancer

It is increasingly recognized that the variation in fibrinogen concentration is associated with the treatment of malignancies. Zhu et al. [21] showed that fibrinogen levels decreased after one and two chemotherapy cycles in patients with small cell lung cancer (SCLC), and the degree of decline was associated with the treatment response. Morano et al. [32] also revealed that serum fibrinogen levels were significantly reduced after 4 weeks of pulmonary rehabilitation in patients with lung cancer.

Some investigators have focused on the therapeutic strategies for controlling tumor metastasis by improving the hypercoagulable status. As reported in the previous studies, the inhibition of tissue factor, factor Xa, and thrombin significantly reduced the experimental hematogenous metastasis [33]. Palumbo et al. [17] also found that thrombin inhibitor substantially diminished the metastatic potential of circulating tumor cells in fibrinogen-deficient mice but had no apparent influence on tumor cell proliferation in vitro. Therefore, anticoagulation therapy may prolong the survival time of patients with cancer.

6 Conclusion

The treatment and prognosis of cancer depend on the tumor stage, presence of comorbidities, and other factors. Various biomarkers and their combinations for tumor progression and prognosis have been explored. The coagulation abnormality in patients with cancer has been recognized for decades. Considerable attention has been paid to the relationship between the progression of lung cancer and fibrinogen. As we have mentioned above, fibrinogen is a valuable biomarker to predict tumor status, EGFR mutation status, and clinical outcome in patients with lung cancer and is associated with tumor progression and metastasis. As a noninvasive method, measurement of fibrinogen is simple, economical, and less traumatic in clinical practice. Further studies are needed to elucidate the relationship between fibrinogen and lung cancer biology.

  1. Conflicts of interest: The authors state no conflict of interest.

References

[1] Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran Jr WJ, Wu YL, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389:299–311.10.1016/S0140-6736(16)30958-8Search in Google Scholar

[2] Cho HI, Lung J. Cancer biomarkers. Adv Clin Chem. 2015;72:107–70.10.1016/bs.acc.2015.07.003Search in Google Scholar

[3] Hassanein M, Callison JC, Callaway-Lane C, Aldrich MC, Grogan EL, Massion PP. The state of molecular biomarkers for the early detection of lung cancer. Cancer Prev Res. 2012;5:992–1006.10.1158/1940-6207.CAPR-11-0441Search in Google Scholar

[4] Jones JM, McGonigle NC, McAnespie M, Cran GW, Graham AN. Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer. Lung Cancer. 2006;53:97–101.10.1016/j.lungcan.2006.03.012Search in Google Scholar

[5] Zhao J, Zhao M, Jin B, Yu P, Hu X, Teng Y, et al. Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen. BMC Cancer. 2012;12:330.10.1186/1471-2407-12-330Search in Google Scholar

[6] Gropp C, Egbring R, Havemann K. Fibrinogen split products, antiproteases and granulocytic elastase in patients with lung cancer. Eur J Cancer. 1980;16:679–85.10.1016/0014-2964(80)90209-1Search in Google Scholar

[7] Yamaguchi T, Yamamoto Y, Yokota S, Nakagawa M, Ito M, Ogura T. Involvement of interleukin-6 in the elevation of plasma fibrinogen levels in lung cancer patients. Jpn J Clin Oncol. 1998;28:740–4.10.1093/jjco/28.12.740Search in Google Scholar

[8] Jiang HG, Li J, Shi SB, Chen P, Ge LP, Jiang Q, et al. Value of fibrinogen and D-dimer in predicting recurrence and metastasis after radical surgery for non-small cell lung cancer. Med Oncol. 2014;31:22.10.1007/s12032-014-0022-8Search in Google Scholar

[9] Kim KH, Park TY, Lee JY, Lee SM, Yim JJ, Yoo CG, et al. Prognostic significance of initial platelet counts and fibrinogen level in advanced non-small cell lung cancer. J Korean Med Sci. 2014;29:507–11.10.3346/jkms.2014.29.4.507Search in Google Scholar

[10] Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis J, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA. 2005;294:1799–809.Search in Google Scholar

[11] Endler G, Mannhalter C. Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis. Clin Chim Acta. 2003;330:31–55.10.1016/S0009-8981(03)00022-6Search in Google Scholar

[12] Guan J, Xiao N, Qiu C, Li Q, Chen M, Zhang Y, et al. Fibrinogen is associated with EGFR mutation status and lymphatic metastasis in non-small cell lung cancer. Oncol Lett. 2019;17:739–46.10.3892/ol.2018.9652Search in Google Scholar PubMed PubMed Central

[13] Takeuchi H, Ikeuchi S, Kitagawa Y, Shimada A, Oishi T, Isobe Y, et al. Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus. J Gastroen Hepatol. 2007;22:2222–7.10.1111/j.1440-1746.2006.04736.xSearch in Google Scholar PubMed

[14] Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, et al. Platelets and fibrin (ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood. 2005;105:178–85.10.1182/blood-2004-06-2272Search in Google Scholar PubMed

[15] Im JH, Fu W, Wang H, Bhatia SK, Hammer DA, Kowalska MA, et al. Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res. 2004;64:8613–9.10.1158/0008-5472.CAN-04-2078Search in Google Scholar PubMed

[16] Palumbo JS, Potter JM, Kaplan LS, Talmage K, Jackson DG, Degen JL. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res. 2002;62:6966–2.Search in Google Scholar

[17] Palumbo JS, Kombrinck KW, Drew AF, Grimes TS, Kiser JH, Degen JL, et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood. 2000;96:3302–9.10.1182/blood.V96.10.3302Search in Google Scholar

[18] Zheng S, Jia Y, Zhao J. Ganoderma lucidum polysaccharides eradicates the blocking effect of fibrinogen on NK cytotoxicity against melanoma cells. Oncol Lett. 2012;3:613–6.10.3892/ol.2011.515Search in Google Scholar PubMed PubMed Central

[19] Sheng L, Luo M, Sun X, Lin N, Mao W, Su D. Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer. Int J Cancer. 2013;133:2720–5.10.1002/ijc.28284Search in Google Scholar PubMed

[20] Zhu JF, Cai L, Zhang XW, Wen YS, Su XD, Rong TH, et al. High plasma fibrinogen concentration and platelet count unfavorably impact survival in non-small cell lung cancer patients with brain metastases. Chin J Cancer. 2014;33:96.10.5732/cjc.012.10307Search in Google Scholar PubMed PubMed Central

[21] Zhu LR, Li J, Chen P, Jiang Q, Tang XP. Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients. Clin Transl Oncol. 2016;18:178–8.10.1007/s12094-015-1350-7Search in Google Scholar PubMed

[22] Wang H, Zhao J, Zhang M, Han L, Wang M, Xingde L. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer. J Cell Physiol. 2018;233:4216–24.10.1002/jcp.26239Search in Google Scholar PubMed

[23] Chen P, Wang C, Cheng B, Nesa EU, Liu Y, Jia Y, et al. Plasma fibrinogen and serum albumin levels (FA score) act as a promising prognostic indicator in non-small cell lung cancer. Onco Targets Ther. 2017;10:3107.10.2147/OTT.S138854Search in Google Scholar PubMed PubMed Central

[24] Chen S, Yan H, Du J, Li J, Shen B, Ying H, et al. Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: a propensity score matching analysis. Clin Chim Acta. 2018;482:203–8.10.1016/j.cca.2018.04.012Search in Google Scholar PubMed

[25] Li SQ, Jiang YH, Lin J, Zhang J, Sun F, Gao QF, et al. Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals. Cancer Med. 2018;7:1221–31.10.1002/cam4.1428Search in Google Scholar PubMed PubMed Central

[26] Huang W, Wang S, Zhang H, Zhang B, Wang C. Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer. Cancer Bio Med. 2018;15:88.10.20892/j.issn.2095-3941.2017.0124Search in Google Scholar PubMed PubMed Central

[27] Ying J, Zhou D, Gu T, Huang J, Liu H. Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy. BMC Cancer. 2019;19:288.10.1186/s12885-019-5490-ySearch in Google Scholar PubMed PubMed Central

[28] Hou C, Jiang F, Ma H, Zhu Q, Wang Z, Zhao B, et al. Prognostic role of preoperative platelet, fibrinogen, and D-dimer levels in patients with non-small cell lung cancer: A multicenter prospective study. Thorac Cancer. 2019;10:304–11.10.1111/1759-7714.12956Search in Google Scholar PubMed PubMed Central

[29] Liang HG, Gao K, Jia R, Li J, Wang C. Prognostic significance of the combination of preoperative fibrinogen and the neutrophil-lymphocyte ratio in patients with non-small cell lung cancer following surgical resection. Oncol Lett. 2019;17:1435–44.10.3892/ol.2018.9760Search in Google Scholar PubMed PubMed Central

[30] Song SW, Lee HS, Kim MS, Lee JM, Kim JH, Nam BH, et al. Preoperative serum fibrinogen level predicts postoperative pulmonary complications after lung cancer resection. Ann Thorac Surg. 2006;81:1974–81.10.1016/j.athoracsur.2006.01.032Search in Google Scholar PubMed

[31] Zhong H, Qian Y, Fang S, Wang Y, Tang Y, Gu W. Prognostic value of plasma fibrinogen in lung cancer patients: a meta-analysis. J Cancer. 2018;9:3904.10.7150/jca.26360Search in Google Scholar PubMed PubMed Central

[32] Morano MTAP, Mesquita R, Da Silva GPF, Araújo AS, Pinto JMDS, Neto AG, et al. Comparison of the effects of pulmonary rehabilitation with chest physical therapy on the levels of fibrinogen and albumin in patients with lung cancer awaiting lung resection: a randomized clinical trial. BMC Pulm Med. 2014;14:121.10.1186/1471-2466-14-121Search in Google Scholar PubMed PubMed Central

[33] Mueller BM, Ruf W. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J Clin Invest. 1998;101:1372–8.10.1172/JCI930Search in Google Scholar PubMed PubMed Central

Received: 2019-08-18
Revised: 2020-03-11
Accepted: 2020-03-17
Published Online: 2020-06-05

© 2020 Xing Liu and Bin Shi, published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Plant Sciences
  2. Dependence of the heterosis effect on genetic distance, determined using various molecular markers
  3. Plant Growth Promoting Rhizobacteria (PGPR) Regulated Phyto and Microbial Beneficial Protein Interactions
  4. Role of strigolactones: Signalling and crosstalk with other phytohormones
  5. An efficient protocol for regenerating shoots from paper mulberry (Broussonetia papyrifera) leaf explants
  6. Functional divergence and adaptive selection of KNOX gene family in plants
  7. In silico identification of Capsicum type III polyketide synthase genes and expression patterns in Capsicum annuum
  8. In vitro induction and characterisation of tetraploid drumstick tree (Moringa oleifera Lam.)
  9. CRISPR/Cas9 or prime editing? – It depends on…
  10. Study on the optimal antagonistic effect of a bacterial complex against Monilinia fructicola in peach
  11. Natural variation in stress response induced by low CO2 in Arabidopsis thaliana
  12. The complete mitogenome sequence of the coral lily (Lilium pumilum) and the Lanzhou lily (Lilium davidii) in China
  13. Ecology and Environmental Sciences
  14. Use of phosphatase and dehydrogenase activities in the assessment of calcium peroxide and citric acid effects in soil contaminated with petrol
  15. Analysis of ethanol dehydration using membrane separation processes
  16. Activity of Vip3Aa1 against Periplaneta americana
  17. Thermostable cellulase biosynthesis from Paenibacillus alvei and its utilization in lactic acid production by simultaneous saccharification and fermentation
  18. Spatiotemporal dynamics of terrestrial invertebrate assemblages in the riparian zone of the Wewe river, Ashanti region, Ghana
  19. Antifungal activity of selected volatile essential oils against Penicillium sp.
  20. Toxic effect of three imidazole ionic liquids on two terrestrial plants
  21. Biosurfactant production by a Bacillus megaterium strain
  22. Distribution and density of Lutraria rhynchaena Jonas, 1844 relate to sediment while reproduction shows multiple peaks per year in Cat Ba-Ha Long Bay, Vietnam
  23. Biomedical Sciences
  24. Treatment of Epilepsy Associated with Common Chromosomal Developmental Diseases
  25. A Mouse Model for Studying Stem Cell Effects on Regeneration of Hair Follicle Outer Root Sheaths
  26. Morphine modulates hippocampal neurogenesis and contextual memory extinction via miR-34c/Notch1 pathway in male ICR mice
  27. Composition, Anticholinesterase and Antipedicular Activities of Satureja capitata L. Volatile Oil
  28. Weight loss may be unrelated to dietary intake in the imiquimod-induced plaque psoriasis mice model
  29. Construction of recombinant lentiviral vector containing human stem cell leukemia gene and its expression in interstitial cells of cajal
  30. Knockdown of lncRNA KCNQ1OT1 inhibits glioma progression by regulating miR-338-3p/RRM2
  31. Protective effect of asiaticoside on radiation-induced proliferation inhibition and DNA damage of fibroblasts and mice death
  32. Prevalence of dyslipidemia in Tibetan monks from Gansu Province, Northwest China
  33. Sevoflurane inhibits proliferation, invasion, but enhances apoptosis of lung cancer cells by Wnt/β-catenin signaling via regulating lncRNA PCAT6/ miR-326 axis
  34. MiR-542-3p suppresses neuroblastoma cell proliferation and invasion by downregulation of KDM1A and ZNF346
  35. Calcium Phosphate Cement Causes Nucleus Pulposus Cell Degeneration Through the ERK Signaling Pathway
  36. Human Dental Pulp Stem Cells Exhibit Osteogenic Differentiation Potential
  37. MiR-489-3p inhibits cell proliferation, migration, and invasion, and induces apoptosis, by targeting the BDNF-mediated PI3K/AKT pathway in glioblastoma
  38. Long non-coding RNA TUG1 knockdown hinders the tumorigenesis of multiple myeloma by regulating the microRNA-34a-5p/NOTCH1 signaling pathway
  39. Large Brunner’s gland adenoma of the duodenum for almost 10 years
  40. Neurotrophin-3 accelerates reendothelialization through inducing EPC mobilization and homing
  41. Hepatoprotective effects of chamazulene against alcohol-induced liver damage by alleviation of oxidative stress in rat models
  42. FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis
  43. Risk factors for elevated serum colorectal cancer markers in patients with type 2 diabetes mellitus
  44. Effect of hepatic sympathetic nerve removal on energy metabolism in an animal model of cognitive impairment and its relationship to Glut2 expression
  45. Progress in research on the role of fibrinogen in lung cancer
  46. Advanced glycation end product levels were correlated with inflammation and carotid atherosclerosis in type 2 diabetes patients
  47. MiR-223-3p regulates cell viability, migration, invasion, and apoptosis of non-small cell lung cancer cells by targeting RHOB
  48. Knockdown of DDX46 inhibits trophoblast cell proliferation and migration through the PI3K/Akt/mTOR signaling pathway in preeclampsia
  49. Buformin suppresses osteosarcoma via targeting AMPK signaling pathway
  50. Effect of FibroScan test in antiviral therapy for HBV-infected patients with ALT <2 upper limit of normal
  51. LncRNA SNHG15 regulates osteosarcoma progression in vitro and in vivo via sponging miR-346 and regulating TRAF4 expression
  52. LINC00202 promotes retinoblastoma progression by regulating cell proliferation, apoptosis, and aerobic glycolysis through miR-204-5p/HMGCR axis
  53. Coexisting flavonoids and administration route effect on pharmacokinetics of Puerarin in MCAO rats
  54. GeneXpert Technology for the diagnosis of HIV-associated tuberculosis: Is scale-up worth it?
  55. Circ_001569 regulates FLOT2 expression to promote the proliferation, migration, invasion and EMT of osteosarcoma cells through sponging miR-185-5p
  56. Lnc-PICSAR contributes to cisplatin resistance by miR-485-5p/REV3L axis in cutaneous squamous cell carcinoma
  57. BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells
  58. MYL6B drives the capabilities of proliferation, invasion, and migration in rectal adenocarcinoma through the EMT process
  59. Inhibition of lncRNA LINC00461/miR-216a/aquaporin 4 pathway suppresses cell proliferation, migration, invasion, and chemoresistance in glioma
  60. Upregulation of miR-150-5p alleviates LPS-induced inflammatory response and apoptosis of RAW264.7 macrophages by targeting Notch1
  61. Long non-coding RNA LINC00704 promotes cell proliferation, migration, and invasion in papillary thyroid carcinoma via miR-204-5p/HMGB1 axis
  62. Neuroanatomy of melanocortin-4 receptor pathway in the mouse brain
  63. Lipopolysaccharides promote pulmonary fibrosis in silicosis through the aggravation of apoptosis and inflammation in alveolar macrophages
  64. Influences of advanced glycosylation end products on the inner blood–retinal barrier in a co-culture cell model in vitro
  65. MiR-4328 inhibits proliferation, metastasis and induces apoptosis in keloid fibroblasts by targeting BCL2 expression
  66. Aberrant expression of microRNA-132-3p and microRNA-146a-5p in Parkinson’s disease patients
  67. Long non-coding RNA SNHG3 accelerates progression in glioma by modulating miR-384/HDGF axis
  68. Long non-coding RNA NEAT1 mediates MPTP/MPP+-induced apoptosis via regulating the miR-124/KLF4 axis in Parkinson’s disease
  69. PCR-detectable Candida DNA exists a short period in the blood of systemic candidiasis murine model
  70. CircHIPK3/miR-381-3p axis modulates proliferation, migration, and glycolysis of lung cancer cells by regulating the AKT/mTOR signaling pathway
  71. Reversine and herbal Xiang–Sha–Liu–Jun–Zi decoction ameliorate thioacetamide-induced hepatic injury by regulating the RelA/NF-κB/caspase signaling pathway
  72. Therapeutic effects of coronary granulocyte colony-stimulating factor on rats with chronic ischemic heart disease
  73. The effects of yam gruel on lowering fasted blood glucose in T2DM rats
  74. Circ_0084043 promotes cell proliferation and glycolysis but blocks cell apoptosis in melanoma via circ_0084043-miR-31-KLF3 axis
  75. CircSAMD4A contributes to cell doxorubicin resistance in osteosarcoma by regulating the miR-218-5p/KLF8 axis
  76. Relationship of FTO gene variations with NAFLD risk in Chinese men
  77. The prognostic and predictive value of platelet parameters in diabetic and nondiabetic patients with sudden sensorineural hearing loss
  78. LncRNA SNHG15 contributes to doxorubicin resistance of osteosarcoma cells through targeting the miR-381-3p/GFRA1 axis
  79. miR-339-3p regulated acute pancreatitis induced by caerulein through targeting TNF receptor-associated factor 3 in AR42J cells
  80. LncRNA RP1-85F18.6 affects osteoblast cells by regulating the cell cycle
  81. MiR-203-3p inhibits the oxidative stress, inflammatory responses and apoptosis of mice podocytes induced by high glucose through regulating Sema3A expression
  82. MiR-30c-5p/ROCK2 axis regulates cell proliferation, apoptosis and EMT via the PI3K/AKT signaling pathway in HG-induced HK-2 cells
  83. CTRP9 protects against MIA-induced inflammation and knee cartilage damage by deactivating the MAPK/NF-κB pathway in rats with osteoarthritis
  84. Relationship between hemodynamic parameters and portal venous pressure in cirrhosis patients with portal hypertension
  85. Long noncoding RNA FTX ameliorates hydrogen peroxide-induced cardiomyocyte injury by regulating the miR-150/KLF13 axis
  86. Ropivacaine inhibits proliferation, migration, and invasion while inducing apoptosis of glioma cells by regulating the SNHG16/miR-424-5p axis
  87. CD11b is involved in coxsackievirus B3-induced viral myocarditis in mice by inducing Th17 cells
  88. Decitabine shows anti-acute myeloid leukemia potential via regulating the miR-212-5p/CCNT2 axis
  89. Testosterone aggravates cerebral vascular injury by reducing plasma HDL levels
  90. Bioengineering and Biotechnology
  91. PL/Vancomycin/Nano-hydroxyapatite Sustained-release Material to Treat Infectious Bone Defect
  92. The thickness of surface grafting layer on bio-materials directly mediates the immuno-reacitivity of macrophages in vitro
  93. Silver nanoparticles: synthesis, characterisation and biomedical applications
  94. Food Science
  95. Bread making potential of Triticum aestivum and Triticum spelta species
  96. Modeling the effect of heat treatment on fatty acid composition in home-made olive oil preparations
  97. Effect of addition of dried potato pulp on selected quality characteristics of shortcrust pastry cookies
  98. Preparation of konjac oligoglucomannans with different molecular weights and their in vitro and in vivo antioxidant activities
  99. Animal Sciences
  100. Changes in the fecal microbiome of the Yangtze finless porpoise during a short-term therapeutic treatment
  101. Agriculture
  102. Influence of inoculation with Lactobacillus on fermentation, production of 1,2-propanediol and 1-propanol as well as Maize silage aerobic stability
  103. Application of extrusion-cooking technology in hatchery waste management
  104. In-field screening for host plant resistance to Delia radicum and Brevicoryne brassicae within selected rapeseed cultivars and new interspecific hybrids
  105. Studying of the promotion mechanism of Bacillus subtilis QM3 on wheat seed germination based on β-amylase
  106. Rapid visual detection of FecB gene expression in sheep
  107. Effects of Bacillus megaterium on growth performance, serum biochemical parameters, antioxidant capacity, and immune function in suckling calves
  108. Effects of center pivot sprinkler fertigation on the yield of continuously cropped soybean
  109. Special Issue On New Approach To Obtain Bioactive Compounds And New Metabolites From Agro-Industrial By-Products
  110. Technological and antioxidant properties of proteins obtained from waste potato juice
  111. The aspects of microbial biomass use in the utilization of selected waste from the agro-food industry
  112. Special Issue on Computing and Artificial Techniques for Life Science Applications - Part I
  113. Automatic detection and segmentation of adenomatous colorectal polyps during colonoscopy using Mask R-CNN
  114. The impedance analysis of small intestine fusion by pulse source
  115. Errata
  116. Erratum to “Diagnostic performance of serum CK-MB, TNF-α and hs-CRP in children with viral myocarditis”
  117. Erratum to “MYL6B drives the capabilities of proliferation, invasion, and migration in rectal adenocarcinoma through the EMT process”
  118. Erratum to “Thermostable cellulase biosynthesis from Paenibacillus alvei and its utilization in lactic acid production by simultaneous saccharification and fermentation”
Downloaded on 22.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2020-0035/html
Scroll to top button